August 11, 2024
Vitrotest is proud to announce the launch of its latest innovation, HIV -1 Recombinant Proteins p24, designed to enhance HIV-1 Ab detection efforts. These advanced proteins contain immunodominant regions specific to HIV-1, making it highly effective for detecting antibodies to the virus in clinical and research settings. With its precision and reliability, p24 recombinant proteins promise to be a valuable tool for improving diagnostic accuracy in HIV-related studies.